Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Switch Symbol:
EV to Sales: Premium Valuation
Trending lower, above historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
391.90
↑ 47% above average
Average (8y)
266.86
Historical baseline
Range
High:957.31
Low:57.90
CAGR
+16.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 391.90 | -59.1% |
| 2023 | 957.31 | +127.7% |
| 2022 | 420.39 | +87.1% |
| 2021 | 224.67 | +288.0% |
| 2020 | 57.90 | -32.9% |
| 2019 | 86.25 | +14.3% |
| 2018 | 75.47 | +0.8% |
| 2017 | 74.86 | -33.7% |
| 2016 | 112.95 | - |